Online Nucleotide Mapping of mRNAs.
Alexandre GoyonBrandon ScottPeter YehlKelly ZhangPublished in: Analytical chemistry (2024)
Messenger RNA (mRNA) can be sequenced via indirect approaches such as Sanger sequencing and next generation sequencing (NGS), or direct approaches likebottom-up mass spectrometry (MS). Direct sequencing allow the confirmation of RNA modifications. However, the conventional bottom-up MS approach involves time-consuming in-solution digestions that require a large amount of sample, and can lead to the RNase contamination of the LC-MS system and column. Here, we describe a platform that enables online nucleotide mapping of mRNAs via the use of immobilized RNase cartridges and 2D-LC-MS instrumentation. The online approach was compared to conventional offline digestion protocols adapted from two published studies. For this purpose, five model mRNAs of varying lengths (996-4521 nucleotides) and chemistries (unmodified uridine vs 5-methoxyuridine (5moU)) were analyzed. The profiles and sequence coverages obtained after RNase T1 digestion were discussed. The online nucleotide mapping achieved comparable or slightly greater sequence coverage for the 5 mRNAs (5.8-51.5%) in comparison to offline approaches (3.7-50.4%). The sequence coverage was increased to 65.6-85.6 and 69.7-85.0% when accounting for the presence of nonunique digestion products generated by the RNase T1 and A, respectively. The online nucleotide mapping significantly reduced the digestion time (from 15 to <5 min), increased the signal intensity by more than 10-fold in comparison to offline approaches.
Keyphrases
- mass spectrometry
- high resolution
- social media
- health information
- liquid chromatography
- high density
- ms ms
- multiple sclerosis
- single cell
- anaerobic digestion
- capillary electrophoresis
- risk assessment
- high performance liquid chromatography
- gene expression
- high throughput
- amino acid
- ionic liquid
- copy number
- systematic review
- gas chromatography
- climate change
- nucleic acid
- affordable care act
- health risk
- solid phase extraction